status of compounded tirzepatide With B6 (Pyridoxine) Tirzepatide for Weight Loss —

Side effects of GLP-1 RA medications: While GLP-1 RAs offer significant benefits, its important to understand their potential drawbacks

They are manufactured under strict guidelines by Eli Lilly, the pharmaceutical company that holds the patent for Tirzepatide

individual results vary significantly Both medications require adherence to dosing schedule and lifestyle modifications Higher doses generally produce better results but may have more side effects Not everyone reaches maximum doses due to side effect tolerance Actual weight loss depends on starting weight, diet, exercise, and individual metabolism Time to See Results: Semaglutide: Weeks 1-4: Minimal weight loss (adjusting to medication) Weeks 4-12: Noticeable appetite reduction and initial weight loss (5-8 pounds) Weeks 12-24: Steady weight loss (1-2 pounds per week) Weeks 24-68: Continued weight loss at slower pace Tirzepatide: Weeks 1-4: Minimal weight loss (adjusting to medication) Weeks 4-12: Noticeable appetite reduction and initial weight loss (8-12 pounds) Weeks 12-24: Steady weight loss (1.5-2.5 pounds per week) Weeks 24-72: Continued weight loss, often at sustained pace Both medications show continued weight loss throughout the clinical trial periods, with weight loss plateauing around month 16-20 for most participants

Doctors diagnose the condition through physical examination and nerve testing

If soreness is normal DOMS, better sleep, nutrition, hydration, and programming matter more

The recommended dosing schedule is as follows: Weeks 1-4: 0.25 mg once weekly Weeks 5-8: 0.5 mg once weekly Weeks 9-12: 1 mg once weekly Week 13 and beyond: 2.4 mg once weekly Considerations for Plastic Surgery Patients As a plastic surgeon, I often discuss the potential benefits of Mounjaro and Semaglutide with my patients